+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Current status and perspective of antiangiogenic therapy for cancer: urinary cancer



Current status and perspective of antiangiogenic therapy for cancer: urinary cancer



International Journal of Clinical Oncology 11(2): 90-107



Angiogenesis is considered a prerequisite for solid tumor growth. Antiangiogenic therapy reduces tumor size and extends host survival in a number of preclinical animal models. However, in humans antiangiogenic therapy is a poor promoter of tumor regression and has shown minimal effect on patient survival. In urinary cancers, such as renal cell cancer, prostate cancer, and bladder cancer, advanced refractory disease is a good candidate for antiangiogenic therapy because of its resistance to ordinary chemotherapy, radiotherapy, and hormonal therapy. Unique characteristics of molecular mechanisms underlie the induction of angiogenesis in urinary cancers. In this review, we summarize these unique mechanisms and review the results of clinical trials of antiangiogenic therapy for these cancers, discussing prospects and problems relating to antiangiogenic therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048696046

Download citation: RISBibTeXText

PMID: 16622744

DOI: 10.1007/s10147-006-0565-6


Related references

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma. International Journal of Clinical Oncology 11(2): 82-89, 2006

Antiangiogenic therapy for breast cancer current status and future perspectives. The Chinese-German Journal of Clinical Oncology 10(7): 373-379, 2011

Antiangiogenic therapy for metastatic breast cancer: current status and future directions. Drugs 69(2): 167-181, 2009

Tumor angiogenesis and antiangiogenic therapy: current status and perspective. International Journal of Clinical Oncology 11(2): 71-72, 2006

Cancer; the current status of theoretical and practical research. XI. Present status of the radiotherapy and hormone therapy of breast cancer.] cancer. Die Medizinische 12: 379-385, 1954

Antiangiogenic therapy for cancer: current and emerging concepts. Oncology 19(4 Suppl 3): 7-16, 2005

Current status and perspective of heavy ion beam therapy for patients with pelvic recurrence after primarily resected rectal cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 36(8): 1263-1266, 2009

Antiangiogenic drugs: current knowledge and new approaches to cancer therapy. Journal of Pharmaceutical Sciences 97(10): 4129-4154, 2008

The 42nd Scientific Meeting: Perspectives of Internal Medicine; Considerations to treatment and care of cancer by internists in the era of increasing cancer mortality; 3. Current Status of Diagnosis and Treatment of Cancer; 3) Cancer biomarker and individualized therapy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(3): 449-455, 2016

Current status of bladder cancer protocols in the european organization for research on treatment of cancer genito urinary group. Kuss, R Et Al (Ed ) Progress in Clinical And Biological Research, Vol 162 Bladder Cancer, Part B: Radiation, Local And Systemic Chemotherapy, And New Treatment Modalities; Proceedings Of The 1st International Symposium on Tumors Of The Urinary Bladder, Paris, France, July 4-6, 1983, Xxiii+453p Alan R Liss, Inc : New York, N Y , Usa Illus 429-440, 1984

Current status of european organization for research on treatment of cancer genito urinary group protocols for bladder cancer. Denis, L Et Al (Ed ) Monograph Series Of The European Organization For Research on Treatment Of Cancer (Eortc), Vol 13 Controlled Clinical Trials in Urologic Oncology Symposium, Brussels, Belgium Oct 30, 1982 Xx+329p Raven Press: New York, N Y , Usa Illus P215-220, 1984

Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective. Seminars in Cancer Biology 20(2): 116-124, 2010

Current status of gene therapy for lung cancer and head and neck cancer. Clinical Cancer Research 9(14): 5055-5067, 2003

Spectroscopic sensing of cancer and cancer therapy: current status of translational research. Cancer Biology & Therapy 3(3): 259-267, 2004

Current status of cancer therapy. 1. Progress in imaging diagnosis of cancer. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 87(9): 1752-1757, 1998